Abstract
Alzheimers disease (AD) is the most common neurodegenerative disease associated with aging. One important pathologic feature of AD is the formation of extracellular senile plaques in the brain, whose major components are small peptides called β-amyloid (Aβ) that are derived from β-amyloid precursor protein (APP) through sequential cleavages by β-secretase and γ-secretase. Because of the critical role of Aβ in the pathogenesis of AD, unraveling the cellular and molecular events underlying APP/Aβ metabolism has been and remains, of paramount importance to AD research. In this article we will focus on the regulation of APP metabolism leading to Aβ generation. We will review current knowledge of the secretases (α-, β-, and γ- secretases) involved in APP processing and various molecular and cellular mechanisms underlying intracellular trafficking of APP, which is a highly regulated process and whose disturbance has direct impacts on the production of Aβ.
Keywords: Alzheimer's disease, β-amyloid, β-amyloid precursor protein, metabolism, α-secretase, β-secretase, γ-secretase, trafficking
Current Molecular Medicine
Title: Molecular and Cellular Mechanisms for Alzheimers Disease:Understanding APP Metabolism
Volume: 7 Issue: 7
Author(s): Yun-wu Zhang and Huaxi Xu
Affiliation:
Keywords: Alzheimer's disease, β-amyloid, β-amyloid precursor protein, metabolism, α-secretase, β-secretase, γ-secretase, trafficking
Abstract: Alzheimers disease (AD) is the most common neurodegenerative disease associated with aging. One important pathologic feature of AD is the formation of extracellular senile plaques in the brain, whose major components are small peptides called β-amyloid (Aβ) that are derived from β-amyloid precursor protein (APP) through sequential cleavages by β-secretase and γ-secretase. Because of the critical role of Aβ in the pathogenesis of AD, unraveling the cellular and molecular events underlying APP/Aβ metabolism has been and remains, of paramount importance to AD research. In this article we will focus on the regulation of APP metabolism leading to Aβ generation. We will review current knowledge of the secretases (α-, β-, and γ- secretases) involved in APP processing and various molecular and cellular mechanisms underlying intracellular trafficking of APP, which is a highly regulated process and whose disturbance has direct impacts on the production of Aβ.
Export Options
About this article
Cite this article as:
Zhang Yun-wu and Xu Huaxi, Molecular and Cellular Mechanisms for Alzheimers Disease:Understanding APP Metabolism, Current Molecular Medicine 2007; 7 (7) . https://dx.doi.org/10.2174/156652407782564462
DOI https://dx.doi.org/10.2174/156652407782564462 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews Procedure for Identification and Characterization of Drugs Efficient Against Mammalian Prion: From a Yeast-Based Antiprion Drug Screening Assay to In Vivo Mouse Models
Infectious Disorders - Drug Targets Orange Pulp Increases Antioxidant Status and Improves Bone Quality in Orchidectomized Rats
Current Nutrition & Food Science Immunological Mechanism and Clinical Application of PAMP Adjuvants
Recent Patents on Anti-Cancer Drug Discovery Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents 6-Acetyl-5H-thiazolo[3,2-a]pyrimidine Derivatives as the Novel Acetylcholinesterase Inhibitors: Design, Synthesis, and Biological Activity
Medicinal Chemistry Chromosomal Aberrations and Genomic Instability Induced by Topoisomerase- Targeted Antitumour Drugs
Current Medicinal Chemistry - Anti-Cancer Agents Therapeutic Targeting of Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry A Combined Approach Using Patch-Clamp Study and Computer Simulation Study for Understanding Long QT Syndrome and TdP in Women
Current Cardiology Reviews Liposome-linear polyethyleneimine-DNA Nanocomplexes for Gene Delivery: Preparation, Characterization and In Vitro Transfection Activity
Current Nanoscience A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders
Current Pharmaceutical Biotechnology Micro-Nanomaterials for Tumor Microwave Hyperthermia: Design, Preparation, and Application
Current Drug Delivery Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Current Pharmaceutical Design Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme
Current Medicinal Chemistry Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor
Medicinal Chemistry Novel Aspects of Neuronal Differentiation In Vitro and Monitoring with Advanced Biosensor Tools
Current Medicinal Chemistry MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer’s Disease
Current Neurovascular Research Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
Current Alzheimer Research